Phylogeny-directed search for Murine leukemia virus-like retroviruses in vertebrate genomes and in patients suffering from myalgic encephalomyelitis/ chronic fatigue syndrome and prostate cancer

Advances in Virology

Volumn 2011, Issue , 2011, Pages

  Blomberg, Jonas ^a,b   Sheikholvaezin, Ali ^a   Elfaitouri, Amal ^a   Blomberg, Fredrik ^a   Sjösten, Anna ^a   Mattson Ulfstedt, Johan ^a   Pipkorn, Rüdiger ^c   Källander, Clas ^d   Öhrmalm, Christina ^a   Sperber, Göran ^e  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d Cavidi AB   (Sweden)

^e UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMARETROVIRUS; MAMMALIA; MURINAE; MURINE LEUKEMIA VIRUS; VERTEBRATA;

EID: 84863664324     PISSN: 16878639     EISSN: 16878647     Source Type: Journal    
DOI: 10.1155/2011/341294     Document Type: Review

References (213)

1. Lee K., Jones K. S., The path well traveled: using mammalian retroviruses to guide research on XMRV. Molecular Interventions 2010 10 1 20 24 2-s2.0-76149101596 10.1124/mi.10.1.5
2. Paprotka T., Delviks-Frankenberry K. A., Cingoz O., Recombinant origin of the retrovirus XMRV. Science 2011 333 6038 97 101 10.1126/science.1205292
3. Knox K., Carrigan D., Simmons G., No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected. Science 2011 333 6038 94 97 10.1126/science.1204963
4. Silverman R. H., Nguyen C., Weight C. J., Klein E. A., The human retrovirus XMRV in prostate cancer and chronic fatigue syndrome. Nature Reviews Urology 2010 7 7 392 402 2-s2.0-77954541065 10.1038/nrurol.2010.77
5. Klein H. G., HKlein@dtm.cc.nih.gov Dodd R. Y., Hollinger F. B., Katz L. M., Kleinman S., Kimberly McCleary K., Silverman R. H., Stramer S. L., Xenotropic murine leukemia virus-related virus (XMRV) and blood transfusion: report of the AABB interorganizational XMRV task force. Transfusion 2011 51 3 654 661 10.1111/j.1537-2995.2010.03012.x
6. Lombardi V. C., Ruscetti F. W., Gupta J. D., Pfost M. A., Hagen K. S., Peterson D. L., Ruscetti S. K., Bagni R. K., Petrow-Sadowski C., Gold B., Dean M., Silverman R. H., Mikovits J. A., Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 2009 326 5952 585 589 2-s2.0-70350488874 10.1126/science.1179052
7. Kim S., Kim N., Dong B., Boren D., Lee S. A., Das Gupta J., Gaughan C., Klein E. A., Lee C., Silverman R. H., Chow S. A., Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer. Journal of Virology 2008 82 20 9964 9977 2-s2.0-53749107062 10.1128/JVI.01299-08
8. Dong B., Kim S., Hong S., Gupta J. D., Malathi K., Klein E. A., Ganem D., DeRisi J. L., Chow S. A., Silverman R. H., An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proceedings of the National Academy of Sciences of the United States of America 2007 104 5 1655 1660 2-s2.0-33846796310 10.1073/pnas.0610291104 (Pubitemid 46214646)
9. Urisman A., Molinaro R. J., Fischer N., Plummer S. J., Casey G., Klein E. A., Malathi K., Magi-Galluzzi C., Tubbs R. R., Ganem D., Silverman R. H., DeRisi J. L., Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathogens 2006 2 3, article e25 2-s2.0-33645769298 10.1371/journal.ppat.0020025
10. Denner J., Detection of a gammaretrovirus, XMRV, in the human population: open questions and implications for xenotransplantation. Retrovirology 2010 7, article 16 2-s2.0-77949428222 10.1186/1742-4690-7-16
11. Schmidt P., Forsman A., Andersson G., Blomberg J., Korsgren O., Pig islet xenotransplantation: activation of porcine endogenous retrovirus in the immediate post-transplantation period. Xenotransplantation 2005 12 6 450 456 2-s2.0-27144448749 10.1111/j.1399-3089.2005.00244.x (Pubitemid 41499803)
12. Schmidt P., Andersson G., Blomberg J., Malmsten A., Korsgren O., Possible transmission of zoonoses in xenotransplantation: porcine endogenous retroviruses (PERVs) from an immunological point of view. Acta Veterinaria Scandinavica 2004 99 supplement 27 34 2-s2.0-4944246799
13. Bromham L., Clark F., McKee J. J., Discovery of a novel murine type C retrovirus by data mining. Journal of Virology 2001 75 6 3053 3057 2-s2.0-0035123820 10.1128/JVI.75.6.3053-3057.2001 (Pubitemid 32185075)
14. Wolgamot G., Bonham L., Miller A. D., Sequence analysis of Mus dunni endogenous virus reveals a hybrid VL30/gibbon ape leukemia virus-like structure and a distinct envelope. Journal of Virology 1998 72 9 7459 7466 2-s2.0-0031846315 (Pubitemid 28377877)
15. Ribet D., Harper F., Esnault C., Pierron G., Heidmann T., The GLN family of murine endogenous retroviruses contains an element competent for infectious viral particle formation. Journal of Virology 2008 82 9 4413 4419 2-s2.0-42449139753 10.1128/JVI.02141-07 (Pubitemid 351563677)
16. Jung Y. T., Wu T., Kozak C. A., Characterization of recombinant nonecotropic murine leukemia viruses from the wild mouse species mus spretus. Journal of Virology 2003 77 23 12773 12781 2-s2.0-0242576812 10.1128/JVI.77.23.12773-12781.2003 (Pubitemid 37430672)
17. Tipper C. H., Bencsics C. E., Coffin J. M., Characterization of Hortulanus endogenous murine leukemia virus, an endogenous provirus that encodes an infectious murine leukemia virus of a novel subgroup. Journal of Virology 2005 79 13 8316 8329 2-s2.0-20744452470 10.1128/JVI.79.13.8316-8329.2005 (Pubitemid 40853535)
18. Schmidt M., Wirth T., Kröger B., Horak I., Structure and genomic organization of a new family of murine retrovirus-related DNA sequences (muRRS). Nucleic Acids Research 1985 13 10 3461 3470 2-s2.0-0022431540 10.1093/nar/13.10.3461
19. Zhao Y., Jacobs C. P. D., Wang L., Hardies S. C., MuERVC: a new family of murine retrovirus-related repetitive sequences and its relationship to previously known families. Mammalian Genome 1999 10 5 477 481 2-s2.0-0032776398 10.1007/s003359901026 (Pubitemid 29390470)
20. Yi J. M., Kim T. H., Huh J. W., Park K. S., Jang S. B., Kim H. M., Kim H. S., Human endogenous retroviral elements belonging to the HERV-S family from human tissues, cancer cells, and primates: expression, structure, phylogeny and evolution. Gene 2004 342 2 283 292 2-s2.0-7544230404 10.1016/j.gene.2004.08.007 (Pubitemid 39452347)
21. Blomberg J., Benachenhou F., Blikstad V., Sperber G., Mayer J., Classification and nomenclature of endogenous retroviral sequences (ERVs). Problems and recommendations. Gene 2009 448 2 115 123 2-s2.0-70350223641 10.1016/j.gene.2009.06.007
22. Roca A. L., Pecon-Slattery J., O'Brien S. J., Genomically intact endogenous feline leukemia viruses of recent origin. Journal of Virology 2004 78 8 4370 4375 2-s2.0-1842431481 10.1128/JVI.78.8.4370-4375.2004 (Pubitemid 38437241)
23. Kewalramani V. N., Panganiban A. T., Emerman M., Spleen necrosis virus, an avian immunosuppressive retrovirus, shares a receptor with the type D simian retroviruses. Journal of Virology 1992 66 5 3026 3031 2-s2.0-0026552587
24. Kawakami T. G., Kollias G. V. Jr., Holmberg C., Oncogenicity of gibbon type-C myelogenous leukemia virus. International Journal of Cancer 1980 25 5 641 646 2-s2.0-0018844578 (Pubitemid 10156850)
25. Kawakami T. G., Sun L., McDowell T. S., Natural transmission of gibbon leukemia virus. Journal of the National Cancer Institute 1978 61 4 1113 1115 2-s2.0-0018075579 (Pubitemid 9042103)
26. Tarlinton R., Meers J., Young P., Endogenous retroviruses: biology and evolution of the endogenous koala retrovirus. Cellular and Molecular Life Sciences 2008 65 21 3413 3421 2-s2.0-55549093726 10.1007/s00018-008-8499-y
27. Martin J., Herniou E., Cook J., O'Neill R. W., Tristem M., Interclass transmission and phyletic host tracking in murine leukemia virus-related retroviruses. Journal of Virology 1999 73 3 2442 2449 2-s2.0-0033049550 (Pubitemid 29098151)
28. Coffin J. M., Hughes S. H., Varmus H. E., Retroviruses 1997 New York, NY, USA Cold Spring Harbor Laboratory Press
29. Gorelick R. J., Chabot D. J., Ott D. E., Gagliardi T. D., Rein A., Henderson L. E., Arthur L. O., Genetic analysis of the zinc finger in the moloney murine leukemia virus nucleocapsid domain: replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA. Journal of Virology 1996 70 4 2593 2597 2-s2.0-0029986494
30. Jern P., Sperber G. O., Blomberg J., Use of endogenous retroviral sequences (ERVs) and structural markers for retroviral phylogenetic inference and taxonomy. Retrovirology 2005 2, article 50 2-s2.0-27344432183 10.1186/1742-4690-2-50 (Pubitemid 41522413)
31. Aziz D. C., Hanna Z., Jolicoeur P., Severe immunodeficiency disease induced by a defective murine leukaemia virus. Nature 1989 338 6215 505 508 2-s2.0-0024553992 (Pubitemid 19107992)
32. Kubo Y., Nakagawa Y., Kakimi K., Matsui H., Iwashiro M., Kuribayashi K., Masuda T., Hiai H., Hirama T., Yanagawa S. I., Ishimoto A., Presence of transplantable T-lymphoid cells in C57BL/6 mice infected with murine AIDS virus. Journal of Virology 1992 66 9 5691 5695 2-s2.0-0026801060
33. Simard C., Huang M., Jolicoeur P., Establishment of leukemic T-cell lines from mice inoculated with the MAIDS defective virus. Virology 1995 206 1 555 563 2-s2.0-0028888364 10.1016/S0042-6822(95)80072-7
34. Overbaugh J., Riedel N., Hoover E. A., Mullins J. I., Transduction of endogenous envelope genes by feline leukaemia virus in vitro. Nature 1988 332 6166 731 734 2-s2.0-0023951716
35. Rohn J. L., Gwynn S. R., Lauring A. S., Linenberger M. L., Overbaugh J., Viral genetic variation, AIDS, and the multistep nature of carcinogenesis: the feline leukemia virus model. Leukemia 1996 10 12 1867 1869 2-s2.0-0030475857 (Pubitemid 27019630)
36. Roth S. L., Malani N., Bushman F. D., Gammaretroviral integration into nucleosomal target DNA in vivo. Journal of Virology 2011 85 14 7393 7401 10.1128/JVI.00635-11
37. Bushman F. D., Retroviral integration and human gene therapy. Journal of Clinical Investigation 2007 117 8 2083 2086 2-s2.0-34547691354 10.1172/JCI32949 (Pubitemid 47219550)
38. Wu X., Li Y., Crise B., Burgess S. M., Transcription start regions in the human genome are favored targets for MLV integration. Science 2003 300 5626 1749 1751 2-s2.0-0037841763 10.1126/science.1083413 (Pubitemid 36712571)
39. Hacein-Bey-Abina S., Von Kalle C., Schmidt M., McCormack M. P., Wulffraat N., Leboulch P., Lim A., Osborne C. S., Pawliuk R., Morillon E., Sorensen R., Forster A., Fraser P., Cohen J. I., de Saint Basile G., Alexander I., Wintergerst U., Frebourg T., Aurias A., Stoppa-Lyonnet D., Romana S., Radford-Weiss I., Gross F., Valensi F., Delabesse E., Macintyre E., Sigaux F., Soulier J., Leiva L. E., Wissler M., Prinz C., Rabbitts T. H., Le Deist F., Fischer A., Cavazzana-Calvo M., LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003 302 5644 415 419 2-s2.0-0142084745 10.1126/science.1088547 (Pubitemid 37296260)
40. Lamers C. H. J., Willemsen R. A., van Elzakker P. M. M. L., Gratama J. W., Debets R., Gibbon ape leukemia virus poorly replicates in primary human T lymphocytes: implications for safety testing of primary human T lymphocytes transduced with GALV-pseudotyped vectors. Journal of Immunotherapy 2009 32 3 272 279 2-s2.0-67449085171 10.1097/CJI.0b013e318199840a
41. Haraguchi S., Good R. A., Cianciolo G. J., Engelman R. W., Day N. K., Immunosuppressive retroviral peptides: immunopathological implications for immunosuppressive influences of retroviral infections. Journal of Leukocyte Biology 1997 61 6 654 666 2-s2.0-0030985828 (Pubitemid 27276057)
42. Nelson M., Nelson D. S., Cianciolo G. J., Snyderman R., Effects of CKS-17, a synthetic retroviral envelope peptide, on cell-mediated immunity in vivo: immunosuppression, immunogenicity, and relation to immunosuppressive tumor products. Cancer Immunology Immunotherapy 1989 30 2 113 118 2-s2.0-0024326430 10.1007/BF01665962 (Pubitemid 20000877)
43. Enserink M., Chronic fatigue syndrome. New XMRV paper looks good, skeptics admit-yet doubts linger. Science 2010 329 5995 1000 2-s2.0-77956629862 10.1126/science.329.5995.1000
44. Mangeney M., Heidmann T., Tumor cells expressing a retroviral envelope escape immune rejection in vivo. Proceedings of the National Academy of Sciences of the United States of America 1998 95 25 14920 14925 2-s2.0-0032424919 10.1073/pnas.95.25.14920 (Pubitemid 29003732)
45. Schlecht-Louf G., Renard M., Mangeney M., Letzelter C., Richaud A., Ducos B., Bouallaga I., Heidmann T., Retroviral infection in vivo requires an immune escape virulence factor encrypted in the envelope protein of oncoretroviruses. Proceedings of the National Academy of Sciences of the United States of America 2010 107 8 3782 3787 2-s2.0-77649267384 10.1073/pnas.0913122107
46. Yeager M., Wilson-Kubalek E. M., Weiner S. G., Brown P. O., Rein A., Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms. Proceedings of the National Academy of Sciences of the United States of America 1998 95 13 7299 7304 2-s2.0-0032560502 10.1073/pnas.95.13.7299 (Pubitemid 28293246)
47. Blomberg J., Sperber G., Jern P., Benachenhou F., Daniel R., Hejnar J., Skalka A. M., Svoboda J., Towards a retrovirus database, retrobank. Proceedings of the Centennial Retrovirus Meeting 2010 Prague, Czech Republic 19 22 Medimond International Proceedings
48. Sperber G. O., Airola T., Jern P., Blomberg J., Automated recognition of retroviral sequences in genomic data-RetroTector. Nucleic Acids Research 2007 35 15 4964 4976 2-s2.0-34548590461 10.1093/nar/gkm515 (Pubitemid 47394183)
49. Sperber G., Lövgren A., Eriksson N. E., Benachenhou F., Blomberg J., RetroTector online, a rational tool for analysis of retroviral elements in small and medium size vertebrate genomic sequences. BMC Bioinformatics 2009 10 supplement 6, article S4 2-s2.0-67649127388 10.1186/1471-2105-10-S6-S4
50. Jern P., Stoye J. P., Coffin J. M., Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. PLoS Genetics 2007 3 10 2014 2022 2-s2.0-35948967657 10.1371/journal.pgen.0030183 (Pubitemid 350072064)
51. Albritton L. M., Tseng L., Scadden D., Cunningham J. M., A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 1989 57 4 659 666 2-s2.0-0024370460 (Pubitemid 19140646)
52. Haltmeier M., Seifarth W., Blusch J., Erfle V., Hehlmann R., Leib-Mosch C., Identification of S71-related human endogenous retroviral sequences with full-length pol genes. Virology 1995 209 2 550 560 2-s2.0-0029001889 10.1006/viro.1995.1287
53. Kozak C. A., The mouse xenotropic gammaretroviruses and their XPR1 receptor. Retrovirology 2010 7, article 101 2-s2.0-78649470644 10.1186/1742-4690-7-101
54. Stoye J. P., Coffin J. M., Polymorphism of murine endogenous proviruses revealed by using virus class-specific oligonucleotide probes. Journal of Virology 1988 62 1 168 175 2-s2.0-0023874499 (Pubitemid 18050806)
55. Stoye J. P., Coffin J. M., The four classes of endogenous murine leukemia virus: structural relationships and potential for recombination. Journal of Virology 1987 61 9 2659 2669 2-s2.0-0023193267 (Pubitemid 17143425)
56. Lo S. C., Pripuzova N., Li B., Komaroff A. L., Hung G. C., Wang R., Alter H. J., Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proceedings of the National Academy of Sciences of the United States of America 2010 107 36 15874 15879 2-s2.0-77957680484 10.1073/pnas.1006901107
57. Yan Y., Liu Q., Wollenberg K., Martin C., Buckler-White A., Kozak C. A., Evolution of functional and sequence variants of the mammalian XPR1 receptor for mouse xenotropic gammaretroviruses and the human-derived retrovirus XMRV. Journal of Virology 2010 84 22 11970 11980 2-s2.0-78049505896 10.1128/JVI.01549-10
58. Yan Y., Liu Q., Kozak C. A., Six host range variants of the xenotropic/polytropic gammaretroviruses define determinants for entry in the XPR1 cell surface receptor. Retrovirology 2009 6, article 87 2-s2.0-70449704324 10.1186/1742-4690-6-87
59. Jern P., Sperber G. O., Blomberg J., Divergent patterns of recent retroviral integrations in the human and chimpanzee genomes: probable transmissions between other primates and chimpanzees. Journal of Virology 2006 80 3 1367 1375 2-s2.0-31144471343 10.1128/JVI.80.3.1367-1375.2006 (Pubitemid 43134094)
60. Marin M., Lavillette D., Kelly S. M., Kabat D., N-linked glycosylation and sequence changes in a critical negative control region of the ASCT1 and ASCT2 neutral amino acid transporters determine their retroviral receptor functions. Journal of Virology 2003 77 5 2936 2945 2-s2.0-0037370550 10.1128/JVI.77.5.2936-2945.2003 (Pubitemid 36228078)
61. Marin M., Tailor C. S., Nouri A., Kabat D., Sodium-dependent neutral amino acid transporter type 1 is an auxiliary receptor for baboon endogenous retrovirus. Journal of Virology 2000 74 17 8085 8093 2-s2.0-0033870901 10.1128/JVI.74.17.8085-8093.2000 (Pubitemid 30641654)
62. Kavanaugh M. P., Kabat D., Identification and characterization of a widely expressed phosphate transporter/retrovirus receptor family. Kidney International 1996 49 4 959 963 2-s2.0-0029930912 (Pubitemid 26122698)
63. Kavanaugh M. P., Wang H., Boyd C. A., North R. A., Kabat D., Cell surface receptor for ecotropic host-range mouse retroviruses: a cationic amino acid transporter. Archives of Virology 1994 9 supplement 485 494 2-s2.0-0028309203
64. Blond J. L., Lavillette D., Cheynet V., Bouton O., Oriol G., Chapel-Fernandes S., Mandrand B., Mallet F., Cosset F. L., An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. Journal of Virology 2000 74 7 3321 3329 2-s2.0-0034053834 10.1128/JVI.74.7.3321- 3329.2000 (Pubitemid 30143757)
65. Yan Y., Knoper R. C., Kozak C. A., Wild mouse variants of envelope genes of xenotropic/polytropic mouse gammaretroviruses and their XPR1 receptors elucidate receptor determinants of virus entry. Journal of Virology 2007 81 19 10550 10557 2-s2.0-34648819292 10.1128/JVI.00933-07 (Pubitemid 47463328)
66. Hawkins E. C., Saliva and tear tests for feline leukemia virus. Journal of the American Veterinary Medical Association 1991 199 10 1382 1385 2-s2.0-0026425955
67. Jarrett O., Overview of feline leukemia virus research. Journal of the American Veterinary Medical Association 1991 199 10 1279 1281 2-s2.0-0026425919
68. Hardy Jr. W. D., Hess P. W., Essex M., Horizontal transmission of feline leukemia virus in cats. Bibliotheca Haematologica 1975 no.40 67 74
69. Overbaugh J., Miller A. D., Eiden M. V., Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins. Microbiology and Molecular Biology Reviews 2001 65 3 371 389 10.1128/MMBR.65.3.371-389.2001 (Pubitemid 32881711)
70. Adamson M. C., Silver J., Kozak C. A., The mouse homolog of the Gibbon ape leukemia virus receptor: genetic mapping and a possible receptor function in rodents. Virology 1991 183 2 778 781 2-s2.0-0025767922 10.1016/0042-6822(91) 91010-E
71. Mendoza R., Anderson M. M., Overbaugh J., A putative thiamine transport protein is a receptor for feline leukemia virus subgroup A. Journal of Virology 2006 80 7 3378 3385 2-s2.0-33645212091 10.1128/JVI.80.7.3378-3385.2006
72. Sommerfelt M. A., Weiss R. A., Receptor interference groups of 20 retroviruses plating on human cells. Virology 1990 176 1 58 69 2-s2.0-0025271315 10.1016/0042-6822(90)90230-O (Pubitemid 20149668)
73. van der Kuyl A. C., Dekker J. T., Goudsmit J., Discovery of a new endogenous type C retrovirus (FcEV) in cats: evidence for RD-114 being an FcEV(Gag-Pol)/baboon endogenous virus BaEV(Env) recombinant. Journal of Virology 1999 73 10 7994 8002 2-s2.0-0032850722 (Pubitemid 29441658)
74. Takeuchi Y., Cosset F. L. C., Lachmann P. J., Okada H., Weiss R. A., Collins M. K. L., Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. Journal of Virology 1994 68 12 8001 8007 2-s2.0-0028138555 (Pubitemid 24362688)
75. Groom H. C. T., Yap M. W., Galão R. P., Neil S. J. D., Bishop K. N., Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors. Proceedings of the National Academy of Sciences of the United States of America 2010 107 11 5166 5171 2-s2.0-77950414085 10.1073/pnas.0913650107
76. Stieler K., Fischer N., Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV. PLoS ONE 2010 5 7 2-s2.0-77955398967 10.1371/journal.pone.0011738 e11738
77. Carthagena L., Parise M. C., Ringeard M., Chelbi-Alix M. K., Hazan U., Nisole S., Implication of TRIMalpha and TRIMCyp in interferon-induced anti-retroviral restriction activities. Retrovirology 2008 5, article 59 2-s2.0-48549093928 10.1186/1742-4690-5-59
78. Song B., Javanbakht H., Perron M., Park D. H., Stremlau M., Sodroski J., Retrovirus restriction by TRIM5 α variants from Old World and New World primates. Journal of Virology 2005 79 7 3930 3937 2-s2.0-15244346957 10.1128/JVI.79.7.3930-3937.2005 (Pubitemid 40388333)
79. Yap M. W., Nisole S., Lynch C., Stoye J. P., Trim5 α protein restricts both HIV-1 and murine leukemia virus. Proceedings of the National Academy of Sciences of the United States of America 2004 101 29 10786 10791 2-s2.0-3242720240 10.1073/pnas.0402876101 (Pubitemid 38955820)
80. Okeoma C. M., Lovsin N., Peterlin B. M., Ross S. R., APOBEC3 inhibits mouse mammary tumour virus replication in vivo. Nature 2007 445 7130 927 930 2-s2.0-33847200788 10.1038/nature05540
81. Takeda E., Tsuji-Kawahara S., Sakamoto M., Langlois M. A., Neuberger M. S., Rada C., Miyazawa M., Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo. Journal of Virology 2008 82 22 10998 11008 2-s2.0-55549083514 10.1128/JVI.01311-08
82. Knouf E. C., Metzger M. J., Mitchell P. S., Arroyo J. D., Chevillet J. R., Tewari M., Miller A. D., Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rv1 prostate carcinoma cells. Journal of Virology 2009 83 14 7353 7356 2-s2.0-67650453748 10.1128/JVI.00546-09
83. Stieler K., Schulz C., Lavanya M., Aepfelbacher M., Stocking C., Fischer N., Host range and cellular tropism of the human exogenous gammaretrovirus XMRV. Virology 2010 399 1 23 30 2-s2.0-77049083357 10.1016/j.virol.2009.12.028
84. Hohn O., Strohschein K., Brandt A. U., Seeher S., Klein S., Kurth R., Paul F., Meisel C., Scheibenbogen C., Bannert N., bannertn@rki.de No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitro. PLoS ONE 2010 5 12 e15632 10.1371/journal.pone.0015632
85. Cornelissen M., Zorgdrager F., Blom P., Jurriaans S., Repping S., van Leeuwen E., Bakker M., Berkhout B., van der Kuyl A. C., Lack of detection of XMRV in seminal plasma from HIV-1 infected men in The Netherlands. PLoS ONE 2010 5 8 2-s2.0-77957813224 10.1371/journal.pone.0012040 e12040
86. Barnes E., Flanagan P., Brown A., Robinson N., Brown H., McClure M., Oxenius A., Collier J., Weber J., Günthard H. F., Hirschel B., Fidler S., Phillips R., Frater J., Failure to detect xenotropic murine leukemia virus-related virus in blood of individuals at high risk of blood-borne viral infections. Journal of Infectious Diseases 2010 202 10 1482 1485 2-s2.0-78349291176 10.1086/657167
87. Danielson B. P., Ayala G. E., Kimata J. T., Detection of xenotropic murine leukemia virus-related virus in normal and tumor tissue of patients from the southern United States with prostate cancer is dependent on specific polymerase chain reaction conditions. Journal of Infectious Diseases 2010 202 10 1470 1477 2-s2.0-78349249059 10.1086/656146
88. Bannert N., Editorial: is a novel human retrovirus associated with prostate cancer and chronic fatigue syndrome? Future Microbiology 2010 5 5 689 691 2-s2.0-77952375110 10.2217/fmb.10.42
89. Erlwein O., Kaye S., McClure M. O., Weber J., Wills G., Collier D., Wessely S., Cleare A., Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS ONE 2010 5 1 2-s2.0-77649137097 10.1371/journal.pone. 0008519 e8519
90. Groom H. C. T., Boucherit V. C., Makinson K., Randal E., Baptista S., Hagan S., Gow J. W., Mattes F. M., Breuer J., Kerr J. R., Stoye J. P., Bishop K. N., Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology 2010 7, article 10 2-s2.0-77949477796 10.1186/1742-4690-7-10
91. Henrich T. J., Li J. Z., Felsenstein D., Kotton C. N., Plenge R. M., Pereyra F., Marty F. M., Lin N. H., Grazioso P., Crochiere D. M., Eggers D., Kuritzkes D. R., Tsibris A. M. N., Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions. Journal of Infectious Diseases 2010 202 10 1478 1481 2-s2.0-78349238566 10.1086/657168
92. Hong P., Pinghong98@yahoo.com Li J., ljm63hn@yahoo.com.cn Li Y., yongzhelipumc@yahoo.com.cn Failure to detect Xenotropic murine leukaemia virus-related virus in Chinese patients with chronic fatigue syndrome. Virology Journal 2010 7, article 224 10.1186/1743-422X-7-224
93. Hue S., Gray E. R., Gall A., Katzourakis A., Tan C. P., Houldcroft C. J., McLaren S., Pillay D., Futreal A., Garson J. A., Pybus O. G., Kellam P., Towers G. J., Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology 2010 7, article 111 2-s2.0-78650290583 10.1186/1742-4690-7-111
94. Oakes B., Tai A. K., Cingoz O., Henefield M. H., Levine S., Coffin J. M., Huber B. T., Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences. Retrovirology 2010 7, article 109 2-s2.0-78650296100 10.1186/1742-4690-7-109
95. Robinson M. J., Erlwein O. W., Kaye S., Weber J., Cingoz O., Patel A., Walker M. M., Kim W. J., Uiprasertkul M., Coffin J. M., McClure M. O., Mouse DNA contamination in human tissue tested for XMRV. Retrovirology 2010 7, article 108 2-s2.0-78650299460 10.1186/1742-4690-7-108
96. Kaiser J., Chronic fatigue syndrome. Studies point to possible contamination in XMRV findings. Science 2011 331 6013 17 10.1126/science.331. 6013.17
97. Verhaegh G. W., de Jong A. S., Smit F. P., Jannink S. A., Melchers W. J.G., Schalken J. A., j.schalken@uro.umcn.nl Prevalence of human xenotropic murine leukemia virus-related gammaretrovirus (XMRV) in dutch prostate cancer patients. Prostate 2011 71 4 415 420 10.1002/pros.21255
98. van Kuppeveld F. J., de Jong A. S., Lanke K. H., Verhaegh G. W., Melchers W. J., Swanink C. M., Bleijenberg G., Netea M. G., Galama J. M., van der Meer J. W., Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort. British Medical Journal 2010 340, article c1018 2-s2.0-77949495226 10.1136/bmj.c1018
99. Garson J. A., j.garson@ucl.ac.uk Kellam P., pk5@sanger.ac.uk Towers G. J., g.towers@ucl.ac.uk Analysis of XMRV integration sites from human prostate cancer tissues suggests PCR contamination rather than genuine human infection. Retrovirology 2011 8, article 13 10.1186/1742-4690-8-13
100. Smith R. A., Contamination of clinical specimens with MLV-encoding nucleic acids: implications for XMRV and other candidate human retroviruses. Retrovirology 2010 7, article 112 2-s2.0-78650289504 10.1186/1742-4690-7-112
101. Sato E., Furuta R. A., Miyazawa T., An endogenous murine leukemia viral genome contaminant in a commercial RT-PCR Kit is amplified using standard primers for XMRV. Retrovirology 2010 7, article 110 2-s2.0-78650258862 10.1186/1742-4690-7-110
102. Mikovits J. A., Huang Y., Pfost M. A., Lombardi V. C., Bertolette D. C., Hagen K. S., Ruscetti F. W., Distribution of xenotropic murine leukemia virus-related virus (XMRV) infection in chronic fatigue syndrome and prostate cancer. AIDS Reviews 2010 12 3 149 152 2-s2.0-78049490034
103. Mikovits J. A., Lombardi V. C., Pfost M. A., Hagen K. S., Ruscetti F. W., Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Virulence 2010 1 5 386 390 2-s2.0-77955148449 10.4161/viru.1.5.12486
104. Arnold R. S., Makarova N. V., Osunkoya A. O., Suppiah S., Scott T. A., Johnson N. A., Bhosle S. M., Liotta D., Hunter E., Marshall F. F., Ly H., Molinaro R. J., Blackwell J. L., Petros J. A., XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH. Urology 2010 75 4 755 761 2-s2.0-77950226521 10.1016/j.urology.2010.01.038
105. Switzer W. M., Jia H., Hohn O., Zheng H., Tang S., Shankar A., Bannert N., Simmons G., Hendry R. M., Falkenberg V. R., Reeves W. C., Heneine W., Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States. Retrovirology 2010 7, article 57 2-s2.0-77954059170 10.1186/1742-4690-7- 57
106. Hohn O., Krause H., Barbarotto P., Niederstadt L., Beimforde N., Denner J., Miller K., Kurth R., Bannert N., Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients. Retrovirology 2009 6, article 92 2-s2.0-70450273189 10.1186/1742-4690-6-92
107. Sabunciyan S., ssabunc1@jhmi.edu Mandelberg N., Rabkin C. S., Yolken R., Viscidi R., No difference in antibody titers against xenotropic MLV related virus in prostate cancer cases and cancer-free controls. Molecular and Cellular Probes 2011 25 2-3 134 136 10.1016/j.mcp.2011.01.005
108. Furuta R. A., furuta@osaka.bc.jrc.or.jp Miyazawa T., takavet@goo.jp Sugiyama T., tantotempo@i.softbank.jp Kuratsune H., kura@fuksi-kagk-u.ac.jp Ikeda Y., ikeda.yasuhiro@mayo.edu Sato E., esato@virus.kyoto-u.ac.jp Misawa N., nmisawa@virus.kyoto-u.ac.jp Nakatomi Y., nakatomi@med.osaka.cu.ac.jp Sakuma R., ryuta.molv@tmd.ac.jp Yasui K., yasui-kazuta@osaka.bc.jrc.or.jp Yamaguti K., siriusyama@yahoo.co.jp Hirayama F., fumiya-hirayama@osaka.bc.jrc.or.jp No association of xenotropic murine leukemia virus-related virus with prostate cancer or chronic fatigue syndrome in Japan. Retrovirology 2011 8, article 20 10.1186/1742-4690-8-20
109. Qiu X., Swanson P., Luk K. C., Tu B., Villinger F., Das Gupta J., Silverman R. H., Klein E. A., Devare S., Schochetman G., Hackett J., Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies. Retrovirology 2010 7, article 68 2-s2.0-77955545135 10.1186/1742-4690-7-68
110. Schlaberg R., Choe D. J., Brown K. R., Thaker H. M., Singh I. R., XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proceedings of the National Academy of Sciences of the United States of America 2009 106 38 16351 16356 2-s2.0-70349515582 10.1073/pnas.0906922106
111. Chiu C. Y., Rouskin S., Koshy A., Urisman A., Fischer K., Yagi S., Schnurr D., Eckburg P. B., Tompkins L. S., Blackburn B. G., Merker J. D., Patterson B. K., Ganem D., DeRisi J. L., Microarray detection of human parainfluenzavirus 4 infection associated with respiratory failure in an immunocompetent adult. Clinical Infectious Diseases 2006 43 8 e71 e76 2-s2.0-34250691592 10.1086/507896
112. Placencio V. R., Sharif-Afshar A. R., Li X., Huang H., Uwamariya C., Neilson E. G., Shen M. M., Matusik R. J., Hayward S. W., Bhowmick N. A., Stromal transforming growth factor- β signaling mediates prostatic response to androgen ablation by paracrine Wnt activity. Cancer Research 2008 68 12 4709 4718 2-s2.0-49649121331 10.1158/0008-5472.CAN-07-6289
113. Bhowmick N. A., Neilson E. G., Moses H. L., Stromal fibroblasts in cancer initiation and progression. Nature 2004 432 7015 332 337 2-s2.0-9244227134 10.1038/nature03096 (Pubitemid 39551661)
114. Montel V., Mose E. S., Tarin D., Tumor-stromal interactions reciprocally modulate gene expression patterns during carcinogenesis and metastasis. International Journal of Cancer 2006 119 2 251 263 2-s2.0-33745221469 10.1002/ijc.21757
115. Tarin D., Tissue interactions in morphogenesis, morphostasis and carcinogenesis. Journal of Theoretical Biology 1972 34 1 61 72 2-s2.0-0015252982
116. Olumi A. F., Grossfeld G. D., Hayward S. W., Carroll P. R., Tlsty T. D., Cunha G. R., Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Research 1999 59 19 5002 5011 2-s2.0-0033215242 (Pubitemid 29472907)
117. Hayward S. W., Wang Y., Cao M., Yun Kit Hom, Zhang B., Grossfeld G. D., Sudilovsky D., Cunha G. R., Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Research 2001 61 22 8135 8142 2-s2.0-0035890799 (Pubitemid 33091604)
118. Jason L. A., Boulton A., Porter N. S., Jessen T., Njoku M. G., Friedberg F., Classification of myalgic encephalomyelitis/chronic fatigue syndrome by types of fatigue. Behavioral Medicine 2010 36 1 24 31 2-s2.0-77649134975 10.1080/08964280903521370
119. Zachrisson O., Regland B., Jahreskog M., Kron M., Gottfries C. G., A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale). Journal of Psychosomatic Research 2002 52 6 501 509 2-s2.0-0036309513 10.1016/S0022-3999(01)00315-4 (Pubitemid 34759879)
120. Blomberg J., Swedish study comes up empty. Proceedings of the 1st XMRV Conference 2010 Bethesda, Md, USA
121. Zhang L., Gough J., Christmas D., Mattey D. L., Richards S. C. M., Main J., Enlander D., Honeybourne D., Ayres J. G., Nutt D. J., Kerr J. R., Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis. Journal of Clinical Pathology 2010 63 2 156 164 2-s2.0-77349111558 10.1136/jcp.2009.072561
122. Morch K., mokr@helse-bergen.no Hanevik K., mfakh@med.uib.no Rortveit G., Guri.Rortveit@isf.uib.no Wensaas K.-A., awensaas@online.no Eide G. E., geir.egil.eide@haukeland.no Hausken T., tryh@helse-bergen.no Langeland N., nila@helse-bergen.no Severity of Giardia infection associated with post-infectious fatigue and abdominal symptoms two years after. BMC Infectious Diseases 2009 9, article 206 10.1186/1471-2334-9-206
123. Morch K., Hanevik K., Rortveit G., Wensaas K. A., Langeland N., High rate of fatigue and abdominal symptoms 2 years after an outbreak of giardiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 2009 103 5 530 532 2-s2.0-63449093725 10.1016/j.trstmh.2009.01.010
124. Gardner M. B., Kozak C. A., O'Brien S. J., The Lake Casitas wild mouse: evolving genetic resistance to retroviral disease. Trends in Genetics 1991 7 1 22 27 2-s2.0-0026051159 (Pubitemid 121001897)
125. Jarrett O., Pathogenicity of feline leukemia virus is commonly associated with variant viruses. Leukemia 1992 6 supplement 3 153S 154S
126. Watson R. R., Resistance to intestinal parasites during murine AIDS: role of alcohol and nutrition in immune dysfunction. Parasitology 1993 107 supplement S69 S74 2-s2.0-0027138644 (Pubitemid 24011217)
127. Jolicoeur P., Murine acquired immunodeficiency syndrome (MAIDS): an animal model to study the AIDS pathogenesis. FASEB Journal 1991 5 10 2398 2405 2-s2.0-0025900801 (Pubitemid 21905787)
128. Via C. S., Morse H. C. III, Shearer G. M., Altered immunoregulation and autoimmune aspects of HIV infection: relevant murine models. Immunology Today 1990 11 7 250 255 2-s2.0-0025285143 (Pubitemid 20198990)
129. Watson R. R., A murine retroviurs model for studies of the role of cofactors and ethanol in AIDS development. NIDA Research Monograph Series 1990 96 166 180
130. Watson R. R., Murine models for acquired immune deficiency syndrome. Life Sciences 1989 44 3 3 15 2-s2.0-0024509305
131. Hoover E. A., Quackenbush S. L., Poss M. L., Dornsife R. E., Overbaugh J. M., Donahue P. R., Riedel N. O., Vigilanti G. A., Khiroya R., Mullins J. I., Pathogenic mechanisms of immunodeficiency syndrome and aplastic anemia induced by feline leukemia viruses. Developments in Biological Standardization 1990 72 163 166 2-s2.0-18244414480
132. Overbaugh J., Donahue P. R., Quackenbush S. L., Hoover E. A., Mullins J. I., Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats. Science 1988 239 4842 906 910 2-s2.0-0023836859 (Pubitemid 18065431)
133. Tabata N., Miyazawa M., Fujisawa R., Takei Y. A., Abe H., Hashimoto K., Establishment of monoclonal anti-retroviral gp70 autoantibodies from MRL/lpr lupus mice and induction of glomerular gp70 deposition and pathology by transfer into non-autoimmune mice. Journal of Virology 2000 74 9 4116 4126 2-s2.0-0034002498 10.1128/JVI.74.9.4116-4126.2000 (Pubitemid 30214417)
134. Datta S. K., McConahey P. J., Manny N., Theofilopoulos A. N., Dixon F. J., Schwartz R. S., Genetic studies of autoimmunity and retrovirus expression in crosses of New Zealand Black mice. II. The viral envelope glycoprotein gp70. Journal of Experimental Medicine 1978 147 3 872 881 (Pubitemid 8303498)
135. Schlaberg R., Choe D. J., Brown K. R., Thaker H. M., Singh I. R., XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proceedings of the National Academy of Sciences of the United States of America 2009 106 38 16351 16356 2-s2.0-70349515582 10.1073/pnas.0906922106
136. Takeuchi Y., McClure M. O., Pizzato M., Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research. Journal of Virology 2008 82 24 12585 12588 2-s2.0-57349139455 10.1128/JVI.01726-08
137. Dewannieux M., Ribet D., Heidmann T., Risks linked to endogenous retroviruses for vaccine production: a general overview. Biologicals 2010 38 3 366 370 2-s2.0-77952950737 10.1016/j.biologicals.2010.01.006
138. Weiss R. A., A cautionary tale of virus and disease. BMC Biology 2010 8, article 124 2-s2.0-77956599502 10.1186/1741-7007-8-124
139. Voisset C., Weiss R. A., Griffiths D. J., david.griffiths@moredun.ac.uk Human RNA rumor viruses: the search for novel human retroviruses in chronic disease. Microbiology and Molecular Biology Reviews 2008 72 1 157 196 10.1128/MMBR.00033-07 (Pubitemid 351398059)
140. Forsman A., Uzameckis D., Rönnblom L., Baecklund E., Åleskog A., Bindra A., Pipkorn R., Lejniece S., Kozireva S., Murovska M., Blomberg J., jonas.blomberg@kvir.uu.se Single-tube nested quantitative PCR: a rational and sensitive technique for detection of retroviral DNA. Application to RERV-H/HRV-5 and confirmation of its rabbit origin. Journal of Virological Methods 2003 111 1 1 11 10.1016/S0166-0934(03)00127-7 (Pubitemid 36725040)
141. Hartley J. W., Evans L. H., Green K. Y., Naghashfar Z., Macias A. R., Zerfas P. M., Ward J. M., Expression of infectious murine leukemia viruses by RAW264.7 cells, a potential complication for studies with a widely used mouse macrophage cell line. Retrovirology 2008 5, article 1 2-s2.0-39749129781 10.1186/1742-4690-5-1 (Pubitemid 351309041)
142. Stang A., alexander.stang@rub.de Petrasch-Parwez E., elisabeth.petrasch- parwez@rub.de Brandt S., sabine.brandt@rub.de Dermietzel R., rolf.dermietzel@rub.de Meyer H. E., helmut.e.meyer@rub.de Stühler K., kai.stuehler@rub.de Liffers S.-T., sven-thorsten.liffers@rub.de Überla K., klaus.ueberla@rub.de Grunwald T., thomas.grunwald@rub.de Unintended spread of a biosafety level 2 recombinant retrovirus. Retrovirology 2009 6, article 86 10.1186/1742-4690-6-86
143. Yoshikawa R., Sato E., Miyazawa T., Contamination of infectious RD-114 virus in vaccines produced using non-feline cell lines. Biologicals 2011 39 1 33 37 2-s2.0-78649696812 10.1016/j.biologicals.2010.11.001
144. Malivanova T. F., Litvinov S. V., Antibodies to retroviruses of types C and D in female patients with benign and malignant mammary tumours. Acta Virologica 1990 34 1 19 26 2-s2.0-0025099963 (Pubitemid 20254617)
145. Reeves R. H., O'Brien S. J., Molecular genetic characterization of the RD-114 gene family of endogenous feline retroviral sequences. Journal of Virology 1984 52 1 164 171 2-s2.0-0021231594 (Pubitemid 14000484)
146. Herbrink P., Moen J. E. T., Brouwer J., Warnaar S. O., Detection of antibodies cross-reactive with type C RNA tumor viral p30 protein in human sera and exudate fluids. Cancer Research 1980 40 1 166 173 2-s2.0-0018835478 (Pubitemid 10179658)
147. Welte K., Ebener U., Chandra P., Serological characterization of a purified reverse transcriptase from osteosarcoma of a child. Cancer Letters 1979 7 4 189 195 2-s2.0-0018584097 (Pubitemid 9252708)
148. Chandra P., Balikcioglu S., Mildner B., Biochemical and immunological characterization of a reverse transcriptase from human melanoma tissue. Cancer Letters 1978 5 6 299 310 2-s2.0-0018173322 (Pubitemid 9064175)
149. Kaplan H. S., Goodenow R. S., Epstein A. L., Gartner S., Decleve A., Rosenthal P. N., Isolation of a type C RNA virus from an established human histiocytic lymphoma cell line. Proceedings of the National Academy of Sciences of the United States of America 1977 74 6 2564 2568 (Pubitemid 8113009)
150. Strand M., August J. T., Type C RNA virus gene expression in human tissue. Journal of Virology 1974 14 6 1584 1596 2-s2.0-0016235772
151. McAllister R. M., Nicolson M., Gardner M. B., RD 114 virus compared with feline and murine type C viruses released from RD cells. Nature 1973 242 116 75 78
152. Ilyin K. V., Kzhyshkowska J. G., Imamova L. R., Mashkova T. D., Ostashkin A. S., Kiselev A. V., Gordina G. A., Kurmashow V. I., Itkes A. V., Type D retrovirus specific sequences in lymphocytes of the children with Burkitt-type lymphoma and their parents. Immunology Letters 2001 78 1 51 54 2-s2.0-0035423559 10.1016/S0165-2478(01)00222-X (Pubitemid 32709907)
153. Hofmann W., Reichart B., Ewald A., Müller E., Schmitt I., Stauber R. H., Lottspeich F., Jockusch B. M., Scheer U., Hauber J., Dabauvalle M. C., Cofactor requirements for nuclear export of Rev response element (RRE)- and constitutive transport element (CTE)-containing retroviral RNAs: an unexpected role for actin. Journal of Cell Biology 2001 152 5 895 910 2-s2.0-0035809913 10.1083/jcb.152.5.895 (Pubitemid 34286067)
154. Kzhyshkowska J. G., Kiselev A. V., Gordina G. A., Kurmashow V. I., Portjanko N. M., Ostashkin A. S., Ilyin K. V., Markers of type D retroviruses in children with Burkitt's-type lymphoma. Immunology Letters 1996 53 2-3 101 104 2-s2.0-0030293075 10.1016/S0165-2478(96)02625-9 (Pubitemid 27038993)
155. Ford R. J., Donehower L. A., Bohannon R. C., Studies on a type D retrovirus isolated from an AIDS patient lymphoma. AIDS Research and Human Retroviruses 1992 8 5 742 751 2-s2.0-0026970212 (Pubitemid 23130930)
156. Bohannon R. C., Donehower L. A., Ford R. J., Isolation of a type D retrovirus from B-cell lymphomas of a patient with AIDS. Journal of Virology 1991 65 11 5663 5672 2-s2.0-0025983562
157. Donehower L. A., Bohannon R. C., Ford R. J., Gibbs R. A., The use of primers from highly conserved pol regions to identify uncharacterized retorviruses by the polymerase chain reaction. Journal of Virological Methods 1990 28 1 33 46 10.1016/0166-0934(90)90085-T (Pubitemid 20120452)
158. Krause H., Uckert W., Wunderlich V., Use of molecular cloned viral genomes for studies into interrelationship between type D retroviruses from monkey and human cells. Archiv fur Experimentelle Veterinarmedizin 1990 44 6 931 933 2-s2.0-0025660197
159. Krause H., Wunderlich V., Uckert W., Molecular cloning of a type D retrovirus from human cells (PMFV) and its homology to simian acquired immunodeficiency type D retroviruses. Virology 1989 173 1 214 222 2-s2.0-0024416205 (Pubitemid 19268265)
160. Purcell D. F. J., Deacon N. J., McKenzie I. F. C., The human non-lineage antigen CD46 (HuLy-m5) and primate retroviral gp70 molecules share protein-defined antigenic determinants. Immunology and Cell Biology 1989 67 5 279 289 (Pubitemid 19265854)
161. Popovic M., Kalyanaraman V. S., Reitz M. S., Sarngadharan M. G., Identification of the RPMI 8226 retrovirus and its dissemination as a significant contaminant of some widely used human and marmoset cell lines. International Journal of Cancer 1982 30 1 93 99 2-s2.0-0019971709 (Pubitemid 12044241)
162. Fukuda M., Wanebo H. J., Tsuei L., Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses. Journal of the National Cancer Institute 1980 64 3 431 437 (Pubitemid 10127256)
163. Uckert W., Wunderlich V., Bender E., The protein pattern of PMF virus, a type-D retrovirus from malignant permanent human cell lines. Archives of Virology 1980 64 2 155 166 (Pubitemid 10075521)
164. Thiry L., Sprecher-Goldberger S., Bossens M., Neuray F., Cell mediated immune response to simian oncornavirus antigens in pregnant women. Journal of the National Cancer Institute 1978 60 3 527 532 2-s2.0-0018085541 (Pubitemid 8303981)
165. Devare S. G., Arthur L. O., Fine D. L., Stephenson J. R., Primate retroviruses: immunological cross-reactivity between major structural proteins of new and old world primate virus isolates. Journal of Virology 1978 25 3 797 805 2-s2.0-0017879939 (Pubitemid 8295385)
166. Malmsten A., anders.malmsten@bmc.uu.se Ekstrand D. H. L., henric@bmb.leeds.ac.uk Åkerblom L., Gronowitz J. S., Källander C. F.R., Bendinelli M., Matteucci D., A colorimetric reverse transcriptase assay optimized for Moloney murine leukemia virus, and its use for characterization of reverse transcriptases of unknown identity. Journal of Virological Methods 1998 75 1 9 20 10.1016/S0166-0934(98)00091-3 (Pubitemid 28495611)
167. 2+-based reverse transcriptase assay for detection of primate retroviruses. Journal of Clinical Microbiology 1999 37 6 1704 1708 2-s2.0-0032588937 (Pubitemid 29235210)
168. Pyra H., Boni J., Schupbach J., Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement. Proceedings of the National Academy of Sciences of the United States of America 1994 91 4 1544 1548 2-s2.0-0028091322 (Pubitemid 24059049)
169. Fischer N., nfischer@uke.de Schulz C., Stieler K., Hohn O., Lange C., Drosten C., Aepfelbacher M., Xenotropic murine leukemia virus-related gammaretro virus in respiratory tract. Emerging Infectious Diseases 2010 16 6 1000 1002 10.3201/eid1606.100066
170. Lee K., Ruscetti F. W., Lloyd P., Rein A., Fanning-Heidecker G., Kewalramani V. N., Development of a GFP-indicator cell line for the detection of XMRV. Proceedings of the 1st XMRV conference 2010 Bethesda, Md, USA National Institutes of Health
171. Deichmann M., martindeichmann@med.uni-heidelberg.de Huder J. B., Kleist C., Näher H., Schüpbach J., Böni J., Detection of reverse transcriptase activity in human melanoma cell lines and identification of a murine leukemia virus contaminant. Archives of Dermatological Research 2005 296 8 345 352 10.1007/s00403-004-0501-4 (Pubitemid 40310806)
172. Yoshikawa R., Sato E., Igarashi T., Miyazawa T., Characterization of RD-114 virus isolated from a commercial canine vaccine manufactured using CRFK cells. Journal of Clinical Microbiology 2010 48 9 3366 3369 2-s2.0-77956801677 10.1128/JCM.00992-10
173. Miyazawa T., Endogenous retroviruses as potential hazards for vaccines. Biologicals 2010 38 3 371 376 2-s2.0-77952952124 10.1016/j.biologicals.2010.03. 003
174. Miyazawa T., Yoshikawa R., Golder M., Okada M., Stewart H., Palmarini M., Isolation of an infectious endogenous retrovirus in a proportion of live attenuated vaccines for pets. Journal of Virology 2010 84 7 3690 3694 2-s2.0-77949404394 10.1128/JVI.02715-09
175. Zhang M., Lute S., Norling L., Hong C., Safta A., O'Connor D., Bernstein L. J., Wang H., Blank G., Brorson K., Chen Q., qi@gene.com A novel, Q-PCR based approach to measuring endogenous retroviral clearance by capture protein a chromatography. Biotechnology and Bioengineering 2009 102 5 1438 1447 10.1002/bit.22172
176. Chang A., achang@bioreliance.com Dusing S., Practical assay issues with the PERT/PBRT assay: a highly sensitive reverse transcriptase assay. Developments in Biologicals 2006 123 91 97 (Pubitemid 43207153)
177. Blomberg J., Folsch G., Nilsson I., Faldt R., Immunoglobulin G antibodies binding to a synthetic peptide deduced from the nucleotide sequence of the env gene of HTLV I in patients with leukemia and rheumatoid arthritis, HLA sensitized persons and blood donors. Leukemia Research 1985 9 9 1111 1116 2-s2.0-0022344896 (Pubitemid 16230381)
178. Blomberg J., Lawoko A., Pipkorn R., Moyo S., Malmvall B. E., Shao J., Dash R., Tswana S., A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HlV-1-positive sera. AIDS 1993 7 6 759 767 2-s2.0-0027202566 (Pubitemid 23212440)
179. Blomberg J., Moestrup T., Frimand J., Hansson B.-G., Krogsgaard K., Grillner L., Nordenfelt E., HTLV-I and -II in intravenous drug users from Sweden and Denmark. Scandinavian Journal of Infectious Diseases 1994 26 1 23 26 (Pubitemid 24073184)
180. Blomberg J., Robert-Guroff M., Blattner W. A., Pipkorn R., Type- and group-specific continuous antigenic determinants of HTLV. Use of synthetic peptides for serotyping of HTLV-I and -II infection. Journal of Acquired Immune Deficiency Syndromes 1992 5 3 294 302
181. Blomberg J., Vincic E., Jonsson C., Medstrand P., Pipkorn R., Identification of regions of HIV-1 p24 reactive with sera which give indeterminate results in electrophoretic immunoblots with the help of long synthetic peptides. AIDS Research and Human Retroviruses 1990 6 12 1363 1372 2-s2.0-0025681921
182. Klasse P. J., Pipkorn R., Blomberg J., Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects. Proceedings of the National Academy of Sciences of the United States of America 1988 85 14 5225 5229 2-s2.0-0011720846
183. Onlamoon N., Gupta J. D., Sharma P., Rogers K., Suppiah S., Rhea J., Molinaro R. J., Gaughan C., Dong B., Klein E. A., Qiu X., Devare S., Schochetman G., Hackett Jr. J., Silverman R. H., Villinger F., fvillin@emory.edu Infection, viral dissemination, and antibody responses of rhesus macaques exposed to the human gammaretrovirus XMRV. Journal of Virology 2011 85 9 4547 4557 10.1128/JVI.02411-10
184. Sakuma T., Tonne J. M., Squillace K. A., Ohmine S., Thatava T., Peng K.-W., Barry M. A., Ikeda Y., ikeda.yasuhiro@mayo.edu Early events in retrovirus XMRV infection of the wild-derived mouse Mus pahari. Journal of Virology 2011 85 3 1205 1213 10.1128/JVI.00886-10
185. Gillette W. K., Esposito D., Taylor T. E., Hopkins R. F., Bagni R. K., Hartley J. L., Purify First: rapid expression and purification of proteins from XMRV. Protein Expression and Purification 2011 76 2 238 247 2-s2.0-78650633423 10.1016/j.pep.2010.12.003
186. Lillehoj E. P., Ford G. M., Bachmann S., Schröder J., Torrey E. F., Yolken R. H., Serum antibodies reactive with non-human primate retroviruses identified in acute onset schizophrenia. Journal of NeuroVirology 2000 6 6 492 497 (Pubitemid 32098063)
187. Langat D. K., Wango E. O., Owiti G. O., Omollo E. O., Mwenda J. M., Characterisation of retroviral-related antigens expressed in normal baboon placental tissues. African Journal of Health Sciences 1998 5 144 152
188. Szabo B., Toth F. D., Kiss J., Kiss A., Rak K., Antiretroviral immune response and plasma interferon in different phases of chronic granulocytic leukemia. Leukemia Research 1993 17 4 311 323 2-s2.0-0027238730 10.1016/0145-2126(93)90018-G (Pubitemid 23146246)
189. Leib-Mosch C., Bachmann M., Brack-Werner R., Werner T., Erfle V., Hehlmann R., Expression and biological significance of human endogenous retroviral sequences. Leukemia 1992 6 supplement 3 72S 75S 2-s2.0-0026777849
190. Kiss J., Toth F. D., Szabo B., Kiss A., Rak K., Retrovirus-neutralizing antibodies in AML and AMMoL patients: stage-specific distribution. Neoplasma 1989 36 2 191 197 2-s2.0-0024565679 (Pubitemid 19108784)
191. Tóth F. D., Váczi L., Szabó B., Kiss J., Réthy A., Kiss A., Telek B., Kovács I., Kiss C., Rák K., Detection of main core proteins of simian C-type viruses and human retrovirus HTLV and antibodies to them in patients with lymphoid malignancies. Acta Microbiologica Hungarica 1985 32 3 267 273
192. Maeda S., Yonezawa K., Yachi A., Serum antibody reacting with placental syncytiotrophoblast in sera of patients with autoimmune diseases-a possible relation to type C RNA retrovirus. Clinical and Experimental Immunology 1985 60 3 645 653 2-s2.0-0021836456 (Pubitemid 15021370)
193. Toth F. D., Vaczi L., Szabo B., Studies on the specificity of human antibodies reacting with GP70 and P15 antigens of baboon endogenous (BaEV) and gibbon ape leukaemia (GaLV) viruses. Acta Virologica 1984 28 3 191 197 2-s2.0-0021238744 (Pubitemid 14110508)
194. Szabó B., Tóth F. D., Váczi L., Réthy A., Kiss A., Rák K., Cellular and humoral cytotoxicity in patients with leukaemia and preleukaemia. II. Oncovirus specificity of the reaction. Acta Microbiologica Hungarica 1984 31 4 365 372
195. Anh-Tuan N., Toth F. D., Szabo B., Antibodies to primate retrovirus antigens in circulating immune complexes of patients with acute myeloid leukemia. Leukemia Research 1984 8 5 863 871 (Pubitemid 14043172)
196. Maeda S., Mellors R. C., Mellors J. W., Immunohistologic detection of antigen related to primate type C retrovirus p30 in normal human placentas. American Journal of Pathology 1983 112 3 347 356 (Pubitemid 13006783)
197. Hehlmann R., Schetters H., Erfle V., Leib-Mosch C., Detection and biochemical characterization of antigens in human leukemic sera that cross-react with primate C-type viral proteins (M(r) 30,000). Cancer Research 1983 43 1 392 399 2-s2.0-0020696304 (Pubitemid 13172847)
198. Wernicke D., Kurth R., Human antibodies recognizing the envelope glycoprotein of the baboon endogenous virus BaEV are of heterophil origin. Medical Microbiology and Immunology 1981 170 2 135 143 (Pubitemid 12253363)
199. Toth F. D., Vaczi L., Kiss J., Detection by radioimmunoassay of antigens related to the P30 polypeptides of primate type C oncoviruses in peripheral leukocytes from patients with chronic myelogenous leukaemia. Acta Virologica 1981 25 6 376 380 (Pubitemid 12170638)
200. Posner L. E., Robert-Guroff M., Kalyanaraan V. S., Natural antibodies to the human T cell lymphoma virus in patients with cutaneous T cell lymphomas. Journal of Experimental Medicine 1981 154 2 333 346 (Pubitemid 11044166)
201. Stass S. A., Phillips T. M., Weislow O. S., Perlin E., Schumacher H. R., Antigen-antibody complexes related to the baboon endogenous virus in humans with acute lymphoblastic leukemia-hand mirror variant (ALL-HMC). Blood 1980 56 4 661 666 (Pubitemid 10005671)
202. Wong-Staal F., Josephs S., Favera R. D., Gallo R., Detection of integrated type-C viral DNA fragments in two primates (human and gibbon) by the restriction enzyme blotting technique. Hamatologie und Bluttransfusion 1979 23 553 560
203. Blomberg J., Nived O., Pipkorn R., Bengtsson A., Erlinge D., Sturfelt G., Increased antiretroviral antibody reactivity in sera from a defined population of patients with systemic lupus erythematosus: correlation with autoantibodies and clinical manifestations. Arthritis and Rheumatism 1994 37 1 57 66 2-s2.0-0027955684 (Pubitemid 24027694)
204. Satterfield B. C., brent@codiagnostics.com Garcia R. A., rebecca@codiagnostics.com Jia H., hjia@cdc.gov Tang S., stang@cdc.gov Zheng H., hzheng@cdc.gov Switzer W. M., bis3@cdc.gov Serologic and PCR testing of persons with chronic fatigue syndrome in the United States shows no association with xenotropic or polytropic murine leukemia virus-related viruses. Retrovirology 2011 8, article 12 10.1186/1742-4690-8-12
205. Metzger M. J., Miller A. D., Acutely transforming retrovirus expressing Nras generated from HT-1080 fibrosarcoma cells infected with the human retrovirus XMRV. Journal of Virology 2010 84 15 7908 7910 2-s2.0-77954490145 10.1128/JVI.00389-10
206. Lawoko A., Johansson B., Rabinayaran D., Pipkorn R., Blomberg J., Increased immunoglobulin G, but not M, binding to endogenous retroviral antigens in HIV-1 infected persons. Journal of Medical Virology 2000 62 4 435 444 2-s2.0-0033745357 10.1002/1096-9071(200012)62:4435::AID-JMV7>3.0.CO;2-R
207. Martin W. J., wjohnmartin@hotmail.com Possible widespread low-level occurrence of murine leukemia virus-related gene sequences in humans. Proceedings of the National Academy of Sciences of the United States of America 2010 107 43 E162 10.1073/pnas.1012930107
208. Krook A., Blomberg J., HTLV-II among injecting drug users in Stockholm. Scandinavian Journal of Infectious Diseases 1994 26 2 129 132 (Pubitemid 24141095)
209. Krook A., Albert J., Andersson S., Biberfeld G., Blomberg J., Eklund I., Engström A., Julander I., Kail K., Martin C., Stendahl P., Struve J., Sönnerborg A., Prevalence and risk factors for HTLV-II infection in 913 injecting drug users in Stockholm, 1994. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1997 15 5 381 386
210. Zanchetta M., Anselmi A., Vendrame D., Rampon O., Giaquinto C., Mazza A., Accapezzato D., Barnaba V., de Rossi A., Early therapy in HIV-1-infected children: effect on HIV-1 dynamics and HIV-1-specific immune response. Antiviral Therapy 2008 13 1 47 55 2-s2.0-42149158210 (Pubitemid 351541673)
211. Pastori C., Barassi C., Lillo F., Longhi R., Capiluppi B., Nozza S., Galli A., Uberti-Foppa C., Lazzarin A., Tambussi G., Lopalco L., The effect of HAART on humoral immune response in primary HIV-1 infected patients. Journal of Biological Regulators and Homeostatic Agents 2002 16 1 9 17 2-s2.0-0036245129 (Pubitemid 34495582)
212. Klein H. G., HKlein@dtm.cc.nih.gov Dodd R. Y., Hollinger F. B., Katz L. M., Kleinman S., McCleary K. K., Silverman R. H., Stramer S. L., Xenotropic murine leukemia virus-related virus (XMRV) and blood transfusion: report of the AABB interorganizational XMRV task force. Transfusion 2011 51 3 654 661 10.1111/j.1537-2995.2010.03012.x
213. Smith R. A., Gottlieb G. S., Miller A. D., Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors. Retrovirology 2010 7, article 70 2-s2.0-77956484577 10.1186/1742-4690-7-70